Mayzent and Tinnitus - a phase IV clinical study of FDA data

Summary:

Tinnitus is reported as a side effect among people who take Mayzent (siponimod fumaric acid), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Vitamin D, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Tinnitus when taking Mayzent. It is created by eHealthMe based on reports of 10,267 people who have side effects when taking Mayzent from the FDA, and is updated regularly.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 10,269 Mayzent users. Check the latest studies of Mayzent.

What is Tinnitus?

Tinnitus (a ringing in the ears) is found to be associated with 1,669 drugs and 3,056 conditions by eHealthMe. Check the latest studies of Tinnitus.

On Jul, 05, 2026

10,267 people reported to have side effects when taking Mayzent.
Among them, 17 people (0.17%) have Tinnitus.

Among these 17 people:

How long have people been on Mayzent when they have Tinnitus? *

What is the gender of people who have Tinnitus when taking Mayzent? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Tinnitus when taking Mayzent? *

What are other drugs people take besides Mayzent? *

What are other side effects people have besides Tinnitus? *

Fatigue (feeling of tiredness): 5 people, 29.41%
Gait Disturbance: 5 people, 29.41%
Headache (pain in head): 5 people, 29.41%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 29.41%
Memory Loss: 5 people, 29.41%
Fall: 4 people, 23.53%
Heart Rate Increased: 4 people, 23.53%
White Blood Cell Count Decreased: 3 people, 17.65%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 17.65%
Dizziness: 3 people, 17.65%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 52.94%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 23.53%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 17.65%
Vitamin D Decreased: 2 people, 11.76%
Stress And Anxiety: 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Depression: 2 people, 11.76%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and have Tinnitus?

- Check whether Tinnitus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mayzent:

Mayzent (10,269 reports)

Tinnitus treatments and more:

Tinnitus (58,552 reports)

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tinnitus:

Tinnitus (1,669 drugs)

Browse all the conditions that are associated with Tinnitus:

Tinnitus (3,056 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.